| Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination J Yu, MD Green, S Li, Y Sun, SN Journey, JE Choi, SM Rizvi, A Qin, ... Nature medicine 27 (1), 152-164, 2021 | 718 | 2021 |
| A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancer MJ Whitley, DM Cardona, AL Lazarides, I Spasojevic, JM Ferrer, J Cahill, ... Science translational medicine 8 (320), 320ra4-320ra4, 2016 | 268 | 2016 |
| Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas KC Cuneo, JJ Vredenburgh, JH Sampson, DA Reardon, A Desjardins, ... International Journal of Radiation Oncology* Biology* Physics 82 (5), 2018-2024, 2012 | 204 | 2012 |
| Histone deacetylase (HDAC) inhibitor LBH589 increases duration of γ-H2AX Foci and confines HDAC4 to the cytoplasm in irradiated non–small cell lung cancer L Geng, KC Cuneo, A Fu, T Tu, PW Atadja, DE Hallahan Cancer research 66 (23), 11298-11304, 2006 | 197 | 2006 |
| Stereotactic body radiation therapy as an alternative to transarterial chemoembolization for hepatocellular carcinoma E Sapir, Y Tao, MJ Schipper, L Bazzi, PM Novelli, P Devlin, D Owen, ... International Journal of Radiation Oncology* Biology* Physics 100 (1), 122-130, 2018 | 181 | 2018 |
| Dose escalation trial of the Wee1 inhibitor adavosertib (AZD1775) in combination with gemcitabine and radiation for patients with locally advanced pancreatic cancer KC Cuneo, MA Morgan, V Sahai, MJ Schipper, LA Parsels, JD Parsels, ... Journal of Clinical Oncology 37 (29), 2643-2650, 2019 | 166 | 2019 |
| PD-L1 expression in circulating tumor cells increases during radio (chemo) therapy and indicates poor prognosis in non-small cell lung cancer Y Wang, TH Kim, S Fouladdel, Z Zhang, P Soni, A Qin, L Zhao, E Azizi, ... Scientific reports 9 (1), 566, 2019 | 151 | 2019 |
| Concurrent stereotactic radiosurgery and bevacizumab in recurrent malignant gliomas: a prospective trial AR Cabrera, KC Cuneo, A Desjardins, JH Sampson, F McSherry, ... International Journal of Radiation Oncology* Biology* Physics 86 (5), 873-879, 2013 | 121 | 2013 |
| Quantitative proteomic analysis of serum exosomes from patients with locally advanced pancreatic cancer undergoing chemoradiotherapy M An, I Lohse, Z Tan, J Zhu, J Wu, H Kurapati, MA Morgan, TS Lawrence, ... Journal of proteome research 16 (4), 1763-1772, 2017 | 113 | 2017 |
| p53 functions in endothelial cells to prevent radiation-induced myocardial injury in mice CL Lee, EJ Moding, KC Cuneo, Y Li, JM Sullivan, L Mao, I Washington, ... Science signaling 5 (234), ra52-ra52, 2012 | 98 | 2012 |
| SU11248 (sunitinib) sensitizes pancreatic cancer to the cytotoxic effects of ionizing radiation KC Cuneo, L Geng, A Fu, D Orton, DE Hallahan, AB Chakravarthy International Journal of Radiation Oncology* Biology* Physics 71 (3), 873-879, 2008 | 96 | 2008 |
| High-performance chemical isotope labeling liquid chromatography mass spectrometry for exosome metabolomics X Luo, M An, KC Cuneo, DM Lubman, L Li Analytical chemistry 90 (14), 8314-8319, 2018 | 95 | 2018 |
| A pilot study of diffusion-weighted MRI in patients undergoing neoadjuvant chemoradiation for pancreatic cancer KC Cuneo, TL Chenevert, E Ben-Josef, MU Feng, JK Greenson, ... Translational Oncology 7 (5), 644-649, 2014 | 88 | 2014 |
| Comparison of stereotactic body radiation therapy and radiofrequency ablation in the treatment of intrahepatic metastases WC Jackson, Y Tao, M Mendiratta-Lala, L Bazzi, DR Wahl, MJ Schipper, ... International Journal of Radiation Oncology* Biology* Physics 100 (4), 950-958, 2018 | 77 | 2018 |
| Improved quantitative 90Y bremsstrahlung SPECT/CT reconstruction with Monte Carlo scatter modeling YK Dewaraja, SY Chun, RN Srinivasa, RK Kaza, KC Cuneo, ... Medical physics 44 (12), 6364-6376, 2017 | 71 | 2017 |
| EGFR targeted therapies and radiation: Optimizing efficacy by appropriate drug scheduling and patient selection KC Cuneo, MK Nyati, D Ray, TS Lawrence Pharmacology & therapeutics 154, 67-77, 2015 | 70 | 2015 |
| A specific antagonist of the p110δ catalytic component of phosphatidylinositol 3′-kinase, IC486068, enhances radiation-induced tumor vascular destruction L Geng, J Tan, E Himmelfarb, A Schueneman, K Niermann, A Fu, ... Cancer research 64 (14), 4893-4899, 2004 | 68 | 2004 |
| Intraoperative detection and removal of microscopic residual sarcoma using wide‐field imaging JK Mito, JM Ferrer, BE Brigman, CL Lee, RD Dodd, WC Eward, ... Cancer 118 (21), 5320-5330, 2012 | 65 | 2012 |
| Imaging findings within the first 12 months of hepatocellular carcinoma treated with stereotactic body radiation therapy M Mendiratta-Lala, E Gu, D Owen, KC Cuneo, L Bazzi, TS Lawrence, ... International Journal of Radiation Oncology* Biology* Physics 102 (4), 1063-1069, 2018 | 64 | 2018 |
| Long term outcomes of stereotactic body radiation therapy for hepatocellular carcinoma without macrovascular invasion AS Mathew, EG Atenafu, D Owen, C Maurino, A Brade, J Brierley, ... European Journal of Cancer 134, 41-51, 2020 | 63 | 2020 |
